Compounds > taurolidine
Page last updated: 2024-08-23

taurolidine and Blood Clot

taurolidine has been researched along with Blood Clot in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Allamani, M; Bonkain, F; Catalano, C; Couttenye, MM; Dhondt, A; Durieux, P; Libertalis, M; Madhoun, P; Stolear, JC; Tielemans, C; Treille, S; Van Craenenbroeck, AH; Van Hulle, F; Van Limberghen, I; Vandervelde, D; Vanommeslaeghe, F; Wissing, KM1
Al-Ali, F; Buanan, H; Elsayed, A; Elsayed, M; Fawzy, A; Hamad, A; Hamdy, AF; Ibrahim, R; Tolba, H; Zafar Iqbal, Z1
Castanheira, M; Pfaffle, AE; Polsky, B; Reidenberg, BE; Shelip, A; Stalleicken, D; Wanner, C1

Trials

2 trial(s) available for taurolidine and Blood Clot

ArticleYear
Prevention of tunneled cuffed catheter dysfunction with prophylactic use of a taurolidine urokinase lock: A randomized double-blind trial.
    PloS one, 2021, Volume: 16, Issue:5

    Topics: Aged; Aged, 80 and over; Catheterization, Central Venous; Central Venous Catheters; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Renal Dialysis; Taurine; Thiadiazines; Thrombosis; Urokinase-Type Plasminogen Activator

2021
Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2018, 04-01, Volume: 33, Issue:4

    Topics: Anti-Infective Agents; Catheter-Related Infections; Catheterization; Female; Fibrinolytic Agents; Heparin; Humans; Incidence; Male; Middle Aged; Prognosis; Prospective Studies; Qatar; Renal Dialysis; Single-Blind Method; Taurine; Thiadiazines; Thrombosis; Urokinase-Type Plasminogen Activator

2018

Other Studies

1 other study(ies) available for taurolidine and Blood Clot

ArticleYear
Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:4

    Topics: Anti-Bacterial Agents; Calcium Citrate; Catheter-Related Infections; Central Venous Catheters; Drug Combinations; Germany; Heparin; Humans; Product Surveillance, Postmarketing; Renal Dialysis; Taurine; Thiadiazines; Thrombosis

2018